DocWire News Editors

DocwireNews

In a study, published in Hematological Oncology, researchers examined the demographic characteristics, pathological features, and clinical disease course in patients with multiple myeloma (MM) plus secondary primary malignancies (SPM), and found that age and autologous stem cell transplantation were independently associated with the clinical outcomes of patients.&nbsp;Interestingly, there was no significant difference in overall survival (OS) observed between patients with or without a SPM, according to lead author, Fei Fei, MD, and colleagues from the Department of Pathology at The University of Alabama at Birmingham.The retrospective chart analysis was performed on 871 patients with MM from the authors&rsquo; center. Among the patients with MM, 40 developed a SPM, of which 17 developed a hematological SPM and 23 developed solid SPM.The median time from the initial diagnosis of MM to the development of SPM was 6.85 years for hematological malignancies and 3.91 years for solid malignancies. The median OS after diagnosis of hematological and solid SPM were 120 and 880 days, respectively.Dr. Fei concluded that the data from the study &ldquo;highlights the importance of understanding the etiology, biology, clinical outcome, and management in patients with MM and a SPM.&rdquo;

Connie Rhee, MD

Joel M. Topf, MD, FACP

CKD Management and Cognition

NKF Spring Clinical Meetings 2025

Bradley Marder, MD

Gout Studies: Transplant Waitlisting and Bone Erosion

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Latest News

Examining Secondary Primary Malignancies in Patients with Multiple Myeloma

Oncology

In a study, published in Hematological Oncology, researchers examined the demographic characteristics, pathological features, and clinical disease course in patients with ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe